Tag
The article describes how a promising Ebola vaccine developed by Thomas Geisbert has remained unused for 15 years due to lack of funding and commercial interest, despite its potential to combat the current Bundibugyo outbreak in Central and East Africa.
Anthropic research reveals that AI agents struggle with biology databases, producing highly variable answers for the same query (e.g., Ebola sequence counts ranging from 5 to 106 vs. expected 266), but adding a repeatable retrieval tool significantly improves consistency and accuracy.
Moderna received $50 million from CEPI to develop an mRNA Ebola vaccine targeting the Bundibugyo strain, amid a severe outbreak in DRC with over 1,000 cases and 241 deaths.
Funding cuts by the Trump administration have halted CREID research centers from responding to the Ebola outbreak in the DRC, hindering diagnostic and surveillance efforts.